<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>161</number>
    <updateDate>2022-11-15T16:33:13Z</updateDate>
    <updateDateIncludingText>2022-11-15T16:33:13Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HRES</type>
    <introducedDate>2013-04-15</introducedDate>
    <congress>113</congress>
    <cdata/>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
            <activities>
              <item>
                <name>Referred to</name>
                <date>2013-04-19T20:06:35Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2013-04-15T16:02:40Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>A resolution expressing the sense of the Senate that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs.</title>
        <congress>113</congress>
        <number>97</number>
        <type>SRES</type>
        <latestAction>
          <actionDate>2013-04-15</actionDate>
          <text>Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S2654)</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2013-04-19</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2013-04-15</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2013-04-15</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2013-04-15</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>R000395</bioguideId>
        <fullName>Rep. Rogers, Harold [R-KY-5]</fullName>
        <firstName>HAROLD</firstName>
        <lastName>ROGERS</lastName>
        <party>R</party>
        <state>KY</state>
        <district>5</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>K000375</bioguideId>
        <fullName>Rep. Keating, William R. [D-MA-9]</fullName>
        <firstName>William</firstName>
        <lastName>Keating</lastName>
        <party>D</party>
        <state>MA</state>
        <middleName>R.</middleName>
        <district>9</district>
        <sponsorshipDate>2013-04-15</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>W000672</bioguideId>
        <fullName>Rep. Wolf, Frank R. [R-VA-10]</fullName>
        <firstName>FRANK</firstName>
        <lastName>WOLF</lastName>
        <party>R</party>
        <state>VA</state>
        <middleName>R.</middleName>
        <district>10</district>
        <sponsorshipDate>2013-04-15</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>R000011</bioguideId>
        <fullName>Rep. Rahall, Nick J., II [D-WV-3]</fullName>
        <firstName>NICK</firstName>
        <lastName>RAHALL</lastName>
        <party>D</party>
        <state>WV</state>
        <middleName>J.</middleName>
        <district>3</district>
        <sponsorshipDate>2013-04-15</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>G000569</bioguideId>
        <fullName>Rep. Grimm, Michael G. [R-NY-11]</fullName>
        <firstName>Michael</firstName>
        <lastName>Grimm</lastName>
        <party>R</party>
        <state>NY</state>
        <middleName>G.</middleName>
        <district>11</district>
        <sponsorshipDate>2013-04-15</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>L000562</bioguideId>
        <fullName>Rep. Lynch, Stephen F. [D-MA-8]</fullName>
        <firstName>Stephen</firstName>
        <lastName>Lynch</lastName>
        <party>D</party>
        <state>MA</state>
        <middleName>F.</middleName>
        <district>8</district>
        <sponsorshipDate>2013-04-15</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>T000266</bioguideId>
        <fullName>Rep. Tierney, John F. [D-MA-6]</fullName>
        <firstName>JOHN</firstName>
        <lastName>TIERNEY</lastName>
        <party>D</party>
        <state>MA</state>
        <middleName>F.</middleName>
        <district>6</district>
        <sponsorshipDate>2013-04-15</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>A000055</bioguideId>
        <fullName>Rep. Aderholt, Robert B. [R-AL-4]</fullName>
        <firstName>ROBERT</firstName>
        <lastName>ADERHOLT</lastName>
        <party>R</party>
        <state>AL</state>
        <middleName>B.</middleName>
        <district>4</district>
        <sponsorshipDate>2013-04-15</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Drug safety, medical device, and laboratory regulation</name>
        </item>
        <item>
          <name>Drug, alcohol, tobacco use</name>
        </item>
        <item>
          <name>Prescription drugs</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2013-04-15</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2013-05-16T15:16:43Z</updateDate>
        <text><![CDATA[ <p>Expresses the sense of the House of Representatives that the Food and Drug Administration (FDA) should exercise its acknowledged authority to: (1) refuse to approve generic versions of non-abuse-deterrent opioid products that have been replaced in the market with abuse-deterrent formulations, and (2) require generic versions of abuse-deterrent opioid products to be formulated with comparable abuse-deterrent features.</p>]]></text>
      </summary>
    </summaries>
    <title>Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs.</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs.</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs.</title>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2013-04-15T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-113hres161ih/xml/BILLS-113hres161ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2013-04-19</actionDate>
      <text>Referred to the Subcommittee on Health.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
